APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Inactive Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Swine Inactive Vaccine Industry Growth and Trends Forecast to 2032

31 December 202590 pages

Choose your research edition.

Industry ResearchSwine Inactive Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Inactive Vaccine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Swine Inactive Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Inactive Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Inactive Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Swine Inactive Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Inactive Vaccine include Zhongmu Industry, Wuhan Keqian Biology, Shenzhen BIOCBD Biotechnology, Shenlian Biomedical, Qindao Lijian Bio-Tech, Jinyu Biotechnology, Harbin Pharmaceutical Group Bio-vaccine, DHN and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Swine Inactive Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Swine Inactive Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Inactive Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Inactive Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Swine Inactive Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Swine Inactive Vaccine Market by Company

Zhongmu Industry

Wuhan Keqian Biology

Shenzhen BIOCBD Biotechnology

Shenlian Biomedical

Qindao Lijian Bio-Tech

Jinyu Biotechnology

Harbin Pharmaceutical Group Bio-vaccine

DHN

Boehringer Ingelheim

Swine Inactive Vaccine Segment by Type

Haemophilus Parasuis Vaccine

Porcine Circovirus Type 2 Vaccine

Mycoplasma Hyopneumoniae Bacterin Vaccine

Others

Swine Inactive Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Inactive Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Inactive Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Inactive Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Inactive Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Inactive Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Swine Inactive Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Haemophilus Parasuis Vaccine Table 2. Major Company of Porcine Circovirus Type 2 Vaccine Table 3. Major Company of Mycoplasma Hyopneumoniae Bacterin Vaccine Table 4. Major Company of Others Table 5. Global Swine Inactive Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 7. Global Swine Inactive Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Swine Inactive Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Swine Inactive Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Swine Inactive Vaccine Price by Type (2021-2026) & (US$/Unit) Table 11. Global Swine Inactive Vaccine Sales by Type (2027-2032) & (K Units) Table 12. Global Swine Inactive Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Swine Inactive Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Swine Inactive Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Swine Inactive Vaccine Price by Type (2027-2032) & (US$/Unit) Table 16. North America Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 17. North America Swine Inactive Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Europe Swine Inactive Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Swine Inactive Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Latin America Swine Inactive Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Swine Inactive Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Swine Inactive Vaccine Industry Trends Table 27. Swine Inactive Vaccine Industry Drivers Table 28. Swine Inactive Vaccine Industry Opportunities and Challenges Table 29. Swine Inactive Vaccine Industry Restraints Table 30. Global Swine Inactive Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Swine Inactive Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Swine Inactive Vaccine Sales by Company (2021-2026) & (K Units) Table 33. Global Swine Inactive Vaccine Sales Share by Company (2021-2026) Table 34. Global Swine Inactive Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Swine Inactive Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Swine Inactive Vaccine Major Company Production Sites and Headquarters Table 37. Global Swine Inactive Vaccine Company, Product Type & Application Table 38. Global Swine Inactive Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Swine Inactive Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Swine Inactive Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Swine Inactive Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Swine Inactive Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Swine Inactive Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Swine Inactive Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Swine Inactive Vaccine Sales by Region (2027-2032) & (K Units) Table 48. Global Swine Inactive Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Swine Inactive Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Swine Inactive Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Swine Inactive Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 54. Global Swine Inactive Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Swine Inactive Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Swine Inactive Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Swine Inactive Vaccine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Swine Inactive Vaccine Sales by Application (2027-2032) & (K Units) Table 59. Global Swine Inactive Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Swine Inactive Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Swine Inactive Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Swine Inactive Vaccine Price by Application (2027-2032) & (US$/Unit) Table 63. North America Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 64. North America Swine Inactive Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Europe Swine Inactive Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Swine Inactive Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Latin America Swine Inactive Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Swine Inactive Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Zhongmu Industry Company Information Table 74. Zhongmu Industry Business Overview Table 75. Zhongmu Industry Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zhongmu Industry Swine Inactive Vaccine Product Portfolio Table 77. Zhongmu Industry Recent Development Table 78. Wuhan Keqian Biology Company Information Table 79. Wuhan Keqian Biology Business Overview Table 80. Wuhan Keqian Biology Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio Table 82. Wuhan Keqian Biology Recent Development Table 83. Shenzhen BIOCBD Biotechnology Company Information Table 84. Shenzhen BIOCBD Biotechnology Business Overview Table 85. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio Table 87. Shenzhen BIOCBD Biotechnology Recent Development Table 88. Shenlian Biomedical Company Information Table 89. Shenlian Biomedical Business Overview Table 90. Shenlian Biomedical Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shenlian Biomedical Swine Inactive Vaccine Product Portfolio Table 92. Shenlian Biomedical Recent Development Table 93. Qindao Lijian Bio-Tech Company Information Table 94. Qindao Lijian Bio-Tech Business Overview Table 95. Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio Table 97. Qindao Lijian Bio-Tech Recent Development Table 98. Jinyu Biotechnology Company Information Table 99. Jinyu Biotechnology Business Overview Table 100. Jinyu Biotechnology Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio Table 102. Jinyu Biotechnology Recent Development Table 103. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 104. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 105. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio Table 107. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 108. DHN Company Information Table 109. DHN Business Overview Table 110. DHN Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. DHN Swine Inactive Vaccine Product Portfolio Table 112. DHN Recent Development Table 113. Boehringer Ingelheim Company Information Table 114. Boehringer Ingelheim Business Overview Table 115. Boehringer Ingelheim Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio Table 117. Boehringer Ingelheim Recent Development Table 118. North America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 120. North America Swine Inactive Vaccine Sales Market Share by Country (2021-2026) Table 121. North America Swine Inactive Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Swine Inactive Vaccine Sales Market Share Forecast by Country (2027-2032) Table 123. North America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Swine Inactive Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Swine Inactive Vaccine Market Share by Country (2021-2026) Table 126. North America Swine Inactive Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Swine Inactive Vaccine Market Share Forecast by Country (2027-2032) Table 128. Europe Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 130. Europe Swine Inactive Vaccine Sales Market Share by Country (2021-2026) Table 131. Europe Swine Inactive Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Swine Inactive Vaccine Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Swine Inactive Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Swine Inactive Vaccine Market Share by Country (2021-2026) Table 136. Europe Swine Inactive Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Swine Inactive Vaccine Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Swine Inactive Vaccine Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Swine Inactive Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Swine Inactive Vaccine Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Swine Inactive Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Swine Inactive Vaccine Market Share by Country (2021-2026) Table 146. Asia-Pacific Swine Inactive Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Swine Inactive Vaccine Market Share Forecast by Country (2027-2032) Table 148. Latin America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 150. Latin America Swine Inactive Vaccine Sales Market Share by Country (2021-2026) Table 151. Latin America Swine Inactive Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Swine Inactive Vaccine Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Swine Inactive Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Swine Inactive Vaccine Market Share by Country (2021-2026) Table 156. Latin America Swine Inactive Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Swine Inactive Vaccine Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Swine Inactive Vaccine Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Swine Inactive Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Swine Inactive Vaccine Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Swine Inactive Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Swine Inactive Vaccine Market Share by Country (2021-2026) Table 166. Middle East and Africa Swine Inactive Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Swine Inactive Vaccine Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Swine Inactive Vaccine Distributors List Table 171. Swine Inactive Vaccine Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Swine Inactive Vaccine Image Figure 2. Global Swine Inactive Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Inactive Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Inactive Vaccine Sales (2021-2032) & (K Units) Figure 5. Haemophilus Parasuis Vaccine Image Figure 6. Global Haemophilus Parasuis Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Porcine Circovirus Type 2 Vaccine Image Figure 8. Global Porcine Circovirus Type 2 Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Mycoplasma Hyopneumoniae Bacterin Vaccine Image Figure 10. Global Mycoplasma Hyopneumoniae Bacterin Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Swine Inactive Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Swine Inactive Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Swine Inactive Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Swine Inactive Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Swine Inactive Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Swine Inactive Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Swine Inactive Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Swine Inactive Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Swine Inactive Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Breeding Farm Image Figure 28. Global Breeding Farm Sales YoY Growth (2021-2032) & (K Units) Figure 29. Veterinary Clinic Image Figure 30. Global Veterinary Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Swine Inactive Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Swine Inactive Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Swine Inactive Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Swine Inactive Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Swine Inactive Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Swine Inactive Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Swine Inactive Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Swine Inactive Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Swine Inactive Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Swine Inactive Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Swine Inactive Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Swine Inactive Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Swine Inactive Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Swine Inactive Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Swine Inactive Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Swine Inactive Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Swine Inactive Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Swine Inactive Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Swine Inactive Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Swine Inactive Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Swine Inactive Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Swine Inactive Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Swine Inactive Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Swine Inactive Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Swine Inactive Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Swine Inactive Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Swine Inactive Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Haemophilus Parasuis Vaccine
  • Porcine Circovirus Type 2 Vaccine
  • Mycoplasma Hyopneumoniae Bacterin Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Zhongmu Industry
  • Wuhan Keqian Biology
  • Shenzhen BIOCBD Biotechnology
  • Shenlian Biomedical
  • Qindao Lijian Bio-Tech
  • Jinyu Biotechnology
  • Harbin Pharmaceutical Group Bio-vaccine
  • DHN
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Inactive Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Swine Inactive Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Swine Inactive Vaccine Market by Type
  6. 1.3.1 Haemophilus Parasuis Vaccine
  7. 1.3.2 Porcine Circovirus Type 2 Vaccine
  8. 1.3.3 Mycoplasma Hyopneumoniae Bacterin Vaccine
  9. 1.3.4 Others
  10. 1.4 Global Swine Inactive Vaccine Market Size by Type
  11. 1.4.1 Global Swine Inactive Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Swine Inactive Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Swine Inactive Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Swine Inactive Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Swine Inactive Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Swine Inactive Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Swine Inactive Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Swine Inactive Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Swine Inactive Vaccine Industry Trends
  2. 2.2 Swine Inactive Vaccine Industry Drivers
  3. 2.3 Swine Inactive Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Inactive Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Swine Inactive Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Swine Inactive Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Swine Inactive Vaccine Price (2021-2026)
  4. 3.4 Global Swine Inactive Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Inactive Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Swine Inactive Vaccine Company, Product Type & Application
  7. 3.7 Global Swine Inactive Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Inactive Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Inactive Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Inactive Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Inactive Vaccine Regional Status and Outlook
  1. 4.1 Global Swine Inactive Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Swine Inactive Vaccine Historic Market Size by Region
  3. 4.2.1 Global Swine Inactive Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Swine Inactive Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Swine Inactive Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Swine Inactive Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Swine Inactive Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Swine Inactive Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Swine Inactive Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Swine Inactive Vaccine by Application
  1. 5.1 Swine Inactive Vaccine Market by Application
  2. 5.1.1 Breeding Farm
  3. 5.1.2 Veterinary Clinic
  4. 5.2 Global Swine Inactive Vaccine Market Size by Application
  5. 5.2.1 Global Swine Inactive Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Swine Inactive Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Swine Inactive Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Swine Inactive Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Swine Inactive Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Swine Inactive Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Swine Inactive Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Swine Inactive Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhongmu Industry
  2. 6.1.1 Zhongmu Industry Company Information
  3. 6.1.2 Zhongmu Industry Business Overview
  4. 6.1.3 Zhongmu Industry Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhongmu Industry Swine Inactive Vaccine Product Portfolio
  6. 6.1.5 Zhongmu Industry Recent Developments
  7. 6.2 Wuhan Keqian Biology
  8. 6.2.1 Wuhan Keqian Biology Company Information
  9. 6.2.2 Wuhan Keqian Biology Business Overview
  10. 6.2.3 Wuhan Keqian Biology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio
  12. 6.2.5 Wuhan Keqian Biology Recent Developments
  13. 6.3 Shenzhen BIOCBD Biotechnology
  14. 6.3.1 Shenzhen BIOCBD Biotechnology Company Information
  15. 6.3.2 Shenzhen BIOCBD Biotechnology Business Overview
  16. 6.3.3 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio
  18. 6.3.5 Shenzhen BIOCBD Biotechnology Recent Developments
  19. 6.4 Shenlian Biomedical
  20. 6.4.1 Shenlian Biomedical Company Information
  21. 6.4.2 Shenlian Biomedical Business Overview
  22. 6.4.3 Shenlian Biomedical Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shenlian Biomedical Swine Inactive Vaccine Product Portfolio
  24. 6.4.5 Shenlian Biomedical Recent Developments
  25. 6.5 Qindao Lijian Bio-Tech
  26. 6.5.1 Qindao Lijian Bio-Tech Company Information
  27. 6.5.2 Qindao Lijian Bio-Tech Business Overview
  28. 6.5.3 Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio
  30. 6.5.5 Qindao Lijian Bio-Tech Recent Developments
  31. 6.6 Jinyu Biotechnology
  32. 6.6.1 Jinyu Biotechnology Company Information
  33. 6.6.2 Jinyu Biotechnology Business Overview
  34. 6.6.3 Jinyu Biotechnology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio
  36. 6.6.5 Jinyu Biotechnology Recent Developments
  37. 6.7 Harbin Pharmaceutical Group Bio-vaccine
  38. 6.7.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  39. 6.7.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  40. 6.7.3 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio
  42. 6.7.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  43. 6.8 DHN
  44. 6.8.1 DHN Company Information
  45. 6.8.2 DHN Business Overview
  46. 6.8.3 DHN Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 DHN Swine Inactive Vaccine Product Portfolio
  48. 6.8.5 DHN Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Swine Inactive Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Swine Inactive Vaccine Sales by Country
  2. 7.1.1 North America Swine Inactive Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Swine Inactive Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Swine Inactive Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Swine Inactive Vaccine Market Size by Country
  6. 7.2.1 North America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Swine Inactive Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Swine Inactive Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Swine Inactive Vaccine Sales by Country
  2. 8.1.1 Europe Swine Inactive Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Swine Inactive Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Swine Inactive Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Swine Inactive Vaccine Market Size by Country
  6. 8.2.1 Europe Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Swine Inactive Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Swine Inactive Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Swine Inactive Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Swine Inactive Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Swine Inactive Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Swine Inactive Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Swine Inactive Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Swine Inactive Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Swine Inactive Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Swine Inactive Vaccine Sales by Country
  2. 10.1.1 South America Swine Inactive Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Swine Inactive Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Swine Inactive Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Swine Inactive Vaccine Market Size by Country
  6. 10.2.1 South America Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Swine Inactive Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Swine Inactive Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Swine Inactive Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Swine Inactive Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Swine Inactive Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Swine Inactive Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Swine Inactive Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Swine Inactive Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Swine Inactive Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Swine Inactive Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Swine Inactive Vaccine Value Chain Analysis
  2. 12.1.1 Swine Inactive Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Swine Inactive Vaccine Production Mode & Process
  7. 12.2 Swine Inactive Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Swine Inactive Vaccine Distributors
  10. 12.2.3 Swine Inactive Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst